Haemonetics HAE Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Haemonetics’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's common stock, shares issued (in shares)?
- Haemonetics (HAE) reported common stock, shares issued (in shares) of $46.83M in Q4 2025.
- How has Haemonetics's common stock, shares issued (in shares) changed year-over-year?
- Haemonetics's common stock, shares issued (in shares) decreased by 6.8% year-over-year, from $50.24M to $46.83M.
- What is the long-term trend for Haemonetics's common stock, shares issued (in shares)?
- Over 4 years (2021 to 2025), Haemonetics's common stock, shares issued (in shares) has grown at a -1.3% compound annual growth rate (CAGR), from $50.87M to $48.22M.